Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality ImprovementRelease Date:Quality Improvement Oncology Kazakhstan Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Title Grant Type Focus Area Country Application Due Date Growth Hormone ResearchRelease Date:Research Rare Disease USA Efforts for early detection of atrial fibrillation and cardioembolic stroke preventionRelease Date:Quality Improvement Internal Medicine Japan Preventing cardiovascular diseases such as venous thromboembolism in cancer patients by raising awareness and promoting medicalRelease Date:Education Internal Medicine Japan Patient Registries In ATTR-CMRelease Date:Quality Improvement Rare Disease Japan Optimizing Menopausal Symptom Management in CanadaRelease Date:Quality Improvement Internal Medicine Canada Optimizing Menopausal Symptom Management in CanadaRelease Date:Quality Improvement Internal Medicine Canada Gene and Anti-TFPI Therapies in HemophiliaRelease Date:Research Rare Disease All Implementing Updated Pneumococcal Immunization Recommendations in AdultsRelease Date:Quality Improvement Vaccines USA Employment support / Lung CancerRelease Date:Education Oncology Japan Biomarker Testing / Lung CancerRelease Date:Education Oncology Japan Cachexia in Cancer – Educational Needs Assessment (USA, Canada, Japan, Italy, UK, Spain, Germany, France)Release Date:Education Internal Medicine Canada, France, Germany, Italy, Japan, Spain, USA, United Kingdom Addressing Knowledge Gaps in the Care of Patients with HR-positive/HER2-negative Advanced Breast CancerRelease Date:Education Oncology Japan